Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenerimod in Chinese Adults With Moderate to Severe Systemic Lupus Erythematosus
CTR20254528Phase 2Active
- Sponsor
- Idorsia
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cenerimod in systemic lupus erythematosus (SLE), sponsored by Idorsia. Started Jan 2026; status: active.
02
Drugs
cenerimod
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20254528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254528.